Press Releases
| Cummings Issues Statement on EPA Administrator Pruitt's Resignation |
| Washington, D.C. (July 5, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement on the resignation of EPA Administrator Scott Pruitt: |
| Washington, D.C. (July 5, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, released new excerpts from transcribed interviews that were conducted by Republican and Democratic Committee staff with top aides to EPA Administrator Scott Pruitt. |
Washington, D.C. (July 5, 2018)—Today, Rep. Elijah E.
Washington, DC – Today, Congressman Mark DeSaulnier and Ranking Member of the Oversight and Government Reform Committee Elijah E. Cummings sent a letter requesting that Chairman Trey Gowdy issue a subpoena to compel the Department of Justice (DOJ) to produce documents it is withholding related to an internal 2006 report that Purdue Pharma knew of significant abuses of its drug OxyContin shortly after it was brought to market in 1996.
Washington, D.C. (July 2, 2018)—Today, Rep. Elijah E. Cummings (D-MD), the Ranking Member of the House Committee on Oversight and Government Reform, Rep. Peter T. King (R-NY), and former Reps. William "Bill" Clay Sr. (D-MO) and Jim Leach (R-IA), filed an amicus brief in the case of AFGE, AFL-CIO et al. v.
Washington, DC - In a letter sent today to Securities and Exchange Commission (SEC) Chairman Jay Clayton, Senator Elizabeth Warren (D-Mass.), Senator Richard Blumenthal (D-Conn.), and Representative Elijah E. Cummings (D-Md.) called on the SEC to investigate whether Secretary of Commerce Wilbur Ross violated insider trading or other securities laws as a result of his investment activities related to Navigator Holdings Ltd - a company with ties to associates of Russian President Vladimir Putin.
Washington, D.C. (June 28, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement at the conclusion of House Republicans' so-called "Opioid Week," which actually extended over parts of the past two weeks: